Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles

References

• Abdel-Rahman O, Elsayed ZA. (2013). Combination Trans Arterial Chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature. Dig Dis Sci 58:3389–96.
   PubMed Web of Science ®Google Scholar
• Altintas I, Heukers R, van der Meel R, et al. (2013). Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. J Control Release 165:110–18.
   PubMed Web of Science ®Google Scholar
• Basu S, et al. (2012). Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study. Int J Nanomedicine 7:6049–61.
   PubMed Web of Science ®Google Scholar
• Dreis S, Rothweiler F, Michaelis M, et al. (2007). Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm 341:207–14.
   PubMed Web of Science ®Google Scholar
• Dubey RD, Alam N, Saneja A, et al. (2015). Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. Int J Pharm 492:80–91.
   PubMed Web of Science ®Google Scholar
• Hawkins MJ, Soon-Shiong P, Desai N, et al. (2008). Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 60:876–85.
   PubMed Web of Science ®Google Scholar
• Kim TH, Jiang HH, Youn YS, et al. (2011). Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–91.
   PubMed Web of Science ®Google Scholar
• Kouchakzadeh H, Shojaosadati SA, Mohammadnejad J, et al. (2012). Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells. Hum Antibodies 21:49–56.
   PubMedGoogle Scholar
• Kouchakzadeh H, Shojaosadati SA, Tahmasebi F, et al. (2013). Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles. Int J Pharm 447:62–9.
   PubMed Web of Science ®Google Scholar
• Kudo M. (2012). Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy. Liver Cancer 1:62–70.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao L, Qi L, et al. (2016). Polymer assembly: promising carriers as co-delivery systems for cancer therapy. Prog Polym Sci 58:1–26.
   Web of Science ®Google Scholar
• Li Y-J, Dong M, Kong F-M, et al. (2015). Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics. Int J Pharm 489:83–90.
   PubMed Web of Science ®Google Scholar
• Liu C, Chen Z, Chen Y, et al. (2016). Improving oral bioavailability of sorafenib by optimizing the "spring" and "parachute" based on molecular interaction mechanisms. Mol Pharmaceutics 13:599–608.
   PubMed Web of Science ®Google Scholar
• Lu Y, Low PS. (2002). Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 54:675–93.
   PubMed Web of Science ®Google Scholar
• Miller AA, Murry DJ, Owzar K, et al. (2009). Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301. J Clin Oncol 27:1800–5.
   PubMed Web of Science ®Google Scholar
• Minami H, Kawada K, Ebi H, et al. (2008). Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors. Cancer Sci 99:1492–8.
   PubMed Web of Science ®Google Scholar
• Pan X, Lee RJ. (2004). Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin Drug Deliv 1:7–17.
   PubMedGoogle Scholar
• Ross JF, Chaudhuri PK, Ratnam M, et al. (1994). Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73:2432–43.
   PubMed Web of Science ®Google Scholar
• Shimada M, Okawa H, Maejima T, et al. (2014). A quantitative HPLC-UV method for determination of serum sorafenib and sorafenib N-oxide and its application in hepatocarcinoma patients. Tohoku J Exp Med 233:103–12.
   PubMed Web of Science ®Google Scholar
• Steinhauser IM, Langer K, Strebhardt KM, et al. (2008). Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation. Biomaterials 29:4022–8.
   PubMed Web of Science ®Google Scholar
• Strumberg D. (2012). Sorafenib for the treatment of renal cancer. Expert Opin Pharmacother 13:407–19.
   PubMed Web of Science ®Google Scholar
• Strumberg D, Clark JW, Awada A, et al. (2007). Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors. Oncologist 12:426–37.
   PubMed Web of Science ®Google Scholar
• Sudimack J, Lee RJ. (2000). Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41:147–62.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, et al. (2009). Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 71:251–6.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Yang W, et al. (2018). Improved oral bioavailability and liver targeting of sorafenib solid lipid nanoparticles in rats. AAPS PharmSciTech 19:761–8.
   PubMed Web of Science ®Google Scholar
• Wang X, Deng Y, Pang T, Cheng G. (2014). Determination of entrapment efficiency for Docetaxel-loaded folate-cojugated Chitosan nanoparticles. Modern Hospital 14:77–9.
   Google Scholar
• Wang Z, Deng Y, Yue X, et al. (2015). Research progress of nano drug delivery system. Guangdong Med J 36:2254–7.
   Google Scholar
• Weitman SD, Weinberg AG, Coney LR, et al. (1992). Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis . Cancer Res 52:6708–11.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gong F, Zhang F, et al. (2013). Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro. Int J Nanomedicine 8:1517–24.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lu J, Jin Y, et al. (2014). Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy. Colloids Surf B Biointerfaces 122:260–9.
   PubMed Web of Science ®Google Scholar
• Zhao J, Xia D, Liu Y, et al. (2015). Research progress of application of folic acid coupled albumin nanoparticles. Shandong Med J 55:97–100.
   Google Scholar
• Zhao L, Li N, Wang K, et al. (2014). A review of polypeptide-based polymersomes. Biomaterials 35:1284–301.
   PubMed Web of Science ®Google Scholar